Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1 ...

Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today ...

The Sentinel, a leading wellness centre, today announced a major initiative advancing the integration of traditional healing ...

Santhera has secured a royalty monetization with existing investor R-Bridge. Pursuant to this transaction, R-Bridge will receive 25% of net royalties on AGAMREE from Catalyst (North America) and ...

Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the ...

PCOS affects up to 20% of reproductive-aged women, making it one of the most prevalent endocrine disorders. However, the ...

All Sky Premium Life products sold in the United States are manufactured locally in GMP-certified, FDA-registered, and ...

A spin out from Imperial College London and the Francis Crick Institute, Myricx is headquartered in London with teams based ...

Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced an update to the previous submission of additional clinical data to the U.S. Food and Drug Administration (FDA) from ongoing third-party ...

SAN FRANCISCO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Until Labs announced today a Series A funding round of $58 million, led by Founders Fund with participation from Lux Capital and Field Ventures. The ...

The Ford government is privatizing our public hospitals in a move that is costing patients thousands of dollars and taking away from our local public hospital services. Everyone’s help is needed to ...